[1]
Love, R. 2021. By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer. Archives of Breast Cancer. (Jan. 2021), 8-13. DOI:https://doi.org/10.32768/abc.2021818-13.